查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1925094

全球神經多樣性評估和篩檢平台市場預測至2032年：按組件、年齡層、部署類型、應用、最終用戶和地區分類

Neurodiversity Assessment & Screening Platforms Market Forecasts to 2032 - Global Analysis By Component (Software Platforms and Services), Age Group, Deployment Mode, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的一項研究，全球神經多樣性評估和篩檢平台市場預計到 2025 年將價值 3.5 億美元，預計到 2032 年將達到 7.8836 億美元。

預計在預測期內，神經多樣性評估和篩檢平台將以12.3%的複合年成長率成長。這些平台是基於技術的解決方案，有助於檢測和了解各種神經系統疾病，例如泛自閉症障礙、注意力不足過動症（ADHD）和學習障礙。它們結合了數位調查問卷、數據分析和智慧演算法，提供準確的篩檢和個人化回饋。這些平台透過支援線上評估和為學校、職場和醫療保健機構提供一致的報告，提高了評估的可近性。它們支持早期發現和持續監測，從而能夠制定更有效的干涉策略和個人化支持計劃。總而言之，這些平台在創造支持性環境方面發揮著至關重要的作用，這些環境能夠認可和尊重學術、臨床和專業環境中的認知多樣性，減少歧視，促進包容。

根據美國國家醫學圖書館 2021 年的研究，自閉症成年人的失業率約為 40%，明顯高於一般人。

人們對神經多樣性的認知不斷提高

機構和社會對神經多樣性的理解不斷加深，是推動市場成長的主要動力。教育機構、醫療機構和雇主越來越將神經差異視為人類多樣性的一部分，催生了對系統性篩檢解決方案的需求。宣傳宣傳活動和支持性政策強調了早期發現和個人化治療的重要性。隨著社會偏見的減少，越來越多的個人和組織願意採用結構化的數位化評估。這種文化轉變推動了對能夠評估認知差異、指導介入措施和支持包容性的便利平台的需求，最終促使神經多樣性評估和篩檢技術在多個領域得到更廣泛的應用。

高昂的實施和維修成本

部署和維護神經多樣性評估平台的高成本限制了市場成長。這些解決方案依賴先進技術，需要大量的初始投資和持續的資金支持。機構還必須為培訓、升級、網路安全和平台整合分配預算。即使認知到長期價值，小規模的機構也往往難以證明這些投資的合理性。因此，成本敏感性成為一大障礙，減緩了採用率，並限制了數位神經多樣性篩檢解決方案的廣泛應用，尤其是在價格敏感的市場中。

拓展至企業人力資源與人才管理領域

包容性招募實踐的日益普及為市場帶來了巨大的成長潛力。企業正在尋求可靠的工具來了解其神經多樣性員工群體，並制定支持性的職場策略。神經多樣性篩檢平台可以整合到人力資源流程中，以確保公平招募、個人化入職和員工發展。透過將個人優勢與職位描述相匹配，企業可以提高員工敬業度和績效。隨著企業越來越重視多元化和包容性，這些平台有機會從醫療保健和教育產業擴展到企業級人才管理解決方案領域。

競爭加劇和市場分散化

日益激烈的競爭壓力對市場穩定構成重大威脅。提供類似篩檢功能的解決方案供應商數量激增，加劇了競爭並導致需求分散。激進的定價策略和缺乏差異化可能會削弱獲利潛力。現有技術公司憑藉其規模和品牌影響力進入市場，進一步加劇了競爭。日益激烈的競爭可能意味著小規模或專注於特定領域的平台提供者難以維持市場佔有率，從而增加了整合或退出市場的可能性，限制了其長期成長機會。

新冠疫情的影響：

新冠疫情顯著影響了神經多樣性評估和篩檢平台市場，推動了虛擬評估技術的快速普及。人際接觸限制減少了面對面評估的機會，迫使學校、診所和機構使用線上篩檢工具。遠端醫療和遠端教育的擴展促進了數位平台的採用。同時，網路存取方面的差異以及對資料安全的擔憂也日益凸顯。這些因素正在影響創新重點，並推動開發更易於存取、更安全、更靈活的神經多樣性篩檢解決方案，以適應後疫情時代的需求。

預計在預測期內，軟體平台細分市場將佔據最大的市場佔有率。

預計在預測期內，軟體平台細分市場將佔據最大的市場佔有率，因為它們構成了神經多樣性篩檢和評估的核心基礎設施。這些平台結合了評估工具、智慧分析和使用者友善的介面，能夠在多個領域實現高效且可重複的篩檢。它們的柔軟性支援線上交付、個人化評估以及與現有系統的無縫整合。機構青睞軟體平台，因為它們簡化了大規模部署，提高了一致性，並減少了對人工流程的依賴。這種功能多樣性和擴充性使得軟體平台成為神經多樣性評估和篩檢解決方案中應用最廣泛的細分市場。

預計在預測期內，成人（18歲及以上）細分市場將達到最高的複合年成長率。

預計在預測期內，18歲及以上成年人群體將呈現最高的成長率。人們越來越意識到，諸如注意力不足過動症（ADHD）、自閉症和閱讀障礙等問題會持續到成年期，這促使更多人接受評估。機構和大學也擴大利用數位化平台來識別支援需求並完善包容性策略。成年人更傾向於柔軟性、私密且線上的篩檢方式，以適應他們忙碌的生活方式。這種成年人評估的趨勢，加上職場包容性舉措和日益增強的自我意識，正在加速成人評估的普及，並使成年人群體成為市場中成長最快的類別。

佔比最大的地區：

預計在預測期內，北美將佔據最大的市場佔有率，這得益於其高度發展的技術生態系統和對神經多樣性的高度重視。該地區受益於醫療保健、教育和就業領域早期對數位化解決方案的整合。各組織正積極利用篩檢平台來支持包容性、合規性和早期療育舉措。熟練專業人員的充足供應、有利的法規環境以及遠端評估工具的高普及率正在推動市場滲透。這些因素共同作用，使北美在整體市場佔有率方面佔據主導地位。

預計年複合成長率最高的地區：

預計亞太地區在預測期內將實現最高的複合年成長率，這主要得益於公眾意識的提高和數位基礎設施的擴展。教育和醫療機構正擴大轉向線上篩檢解決方案，以高效滿足不斷成長的需求。政府支持計畫、行動技術的普及以及對包容性教育日益重視，都在推動這些解決方案的採用。該地區龐大且多元化的人口對便利的評估工具的需求，促使數位神經多樣性平台迅速普及，使亞太地區成為全球成長最快的市場。

免費客製化服務：

購買此報告的客戶可以選擇以下免費自訂選項之一：

  • 公司概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 主要參與者（最多3家公司）的SWOT分析
  • 區域細分
    • 根據客戶要求，提供主要國家的市場估算和預測以及複合年成長率（註：可行性需確認）。
  • 競爭標竿分析
    • 根據主要參與者的產品系列、地理覆蓋範圍和策略聯盟進行基準分析

目錄

第1章執行摘要

第2章 前言

  • 概括
  • 相關利益者
  • 調查範圍
  • 調查方法
  • 研究材料

第3章 市場趨勢分析

  • 促進要素
  • 抑制因素
  • 機會
  • 威脅
  • 應用分析
  • 終端用戶分析
  • 新興市場
  • 新冠疫情的感染疾病

第4章 波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球神經多樣性評估和篩檢平台市場（按組件分類）

  • 軟體平台
  • 服務

6. 全球神經多樣性評估與篩檢平台市場（依年齡層分類）

  • 兒童（0-12歲）
  • 青少年（13-17歲）
  • 成年人（18歲以上）

7. 全球神經多樣性評估與篩檢平台市場（依實施類型分類）

  • 基於雲端的
  • 本地部署

8. 全球神經多樣性評估與篩檢平台市場（按應用分類）

  • 閱讀障礙篩檢
  • ADHD篩檢
  • 泛自閉症障礙（ASD）篩檢
  • 共濟失調篩檢

9. 全球神經多樣性評估和篩檢平台市場（按最終用戶分類）

  • 教育機構
  • 醫療保健提供者
  • 公司組織
  • 研究所
  • 政府機構

10. 全球神經多樣性評估與篩檢平台市場（按地區分類）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 亞太其他地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第11章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 併購
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第12章：企業概況

  • Lumosity
  • MoCA Cognition
  • HappyNeuron
  • Cognistat
  • BrainFx
  • Dystech
  • CogniFit
  • Cambridge Cognition
  • Creyos Health
  • CNS Vital Signs
  • Do-IT Profiler
  • GL Assessment
  • Qbtech
  • Gabify
  • Aignosis
Product Code: SMRC33488

According to Stratistics MRC, the Global Neurodiversity Assessment & Screening Platforms Market is accounted for $350.0 million in 2025 and is expected to reach $788.36 million by 2032 growing at a CAGR of 12.3% during the forecast period. Neurodiversity Assessment & Screening Platforms are technology-based solutions that help detect and understand diverse neurological conditions, such as autism spectrum disorders, ADHD, and learning differences. They combine digital questionnaires, data analysis, and intelligent algorithms to deliver accurate screenings and tailored feedback. These platforms make assessments more accessible by allowing online evaluations and consistent reporting for schools, workplaces, and healthcare providers. By supporting early identification and continuous monitoring, they enable better intervention strategies and personalized support plans. Overall, such platforms play a key role in promoting inclusion, reducing stigma, and creating supportive environments that recognize and value cognitive diversity in academic, clinical, and professional settings.

According to the National Library of Medicine (2021 study), the unemployment rate among autistic adults is around 40%, which is significantly higher than the general population.

Market Dynamics:

Driver:

Growing awareness of neurodiversity

Increasing understanding of neurodiversity among institutions and society is strongly fueling market growth. Educational bodies, healthcare providers, and employers now view neurological differences as part of human diversity, creating demand for systematic screening solutions. Awareness campaigns and supportive policies highlight the importance of early identification and tailored assistance. As stigma declines, more individuals and organizations are willing to adopt structured digital assessments. This cultural shift drives the need for accessible platforms that can evaluate cognitive differences, guide interventions, and support inclusion, ultimately expanding the use of neurodiversity assessment and screening technologies across multiple sectors.

Restraint:

High cost of implementation and maintenance

Elevated costs associated with deploying and maintaining neurodiversity assessment platforms restrict market growth. These solutions rely on sophisticated technologies that demand substantial upfront and ongoing financial resources. Organizations must also allocate budgets for training, upgrades, cybersecurity, and platform integration. Smaller institutions often struggle to justify such investments, even when the long-term value is recognized. As a result, cost sensitivity acts as a barrier, particularly in price-conscious markets, reducing adoption rates and limiting the widespread use of digital neurodiversity screening solutions.

Opportunity:

Expansion into corporate HR and talent management

Rising adoption of inclusive hiring practices presents significant growth potential for the market. Companies are looking for reliable tools to understand neurodiverse talent and design supportive workplace strategies. Neurodiversity screening platforms can be embedded into HR processes to enable fair recruitment, customized onboarding, and employee development. By aligning individual strengths with job roles, organizations can improve engagement and outcomes. As corporate focus on diversity and inclusion intensifies, these platforms gain opportunities to expand beyond healthcare and education into enterprise-level talent management solutions.

Threat:

Intensifying competition and market fragmentation

Rising competitive pressure represents a major threat to market stability. The increasing number of solution providers offering similar screening functionalities intensifies rivalry and fragments demand. Aggressive pricing strategies and limited differentiation can weaken revenue potential. Established technology firms entering the market further heighten competition due to their scale and brand strength. As competition grows, smaller or specialized platform providers may struggle to maintain market share, making consolidation or exit more likely and limiting long-term growth opportunities.

Covid-19 Impact:

COVID-19 strongly influenced the neurodiversity assessment and screening platforms market by driving rapid adoption of virtual assessment technologies. Restrictions on physical interactions reduced the availability of face-to-face evaluations, pushing schools, clinics, and organizations to use online screening tools. Growth in telehealth and remote education supported wider acceptance of digital platforms. At the same time, disparities in internet access and concerns over data security became more visible. These factors shaped innovation priorities, encouraging more accessible, secure, and flexible neurodiversity screening solutions for post-pandemic environments.

The software platforms segment is expected to be the largest during the forecast period

The software platforms segment is expected to account for the largest market share during the forecast period as they form the core infrastructure for neurodiversity screening and evaluation. By combining assessment tools, intelligent analysis, and user-friendly interfaces, these platforms enable efficient and repeatable screenings across multiple sectors. Their flexibility supports online delivery, personalized assessments, and seamless integration with existing systems. Organizations favor software platforms because they simplify large-scale implementation, improve consistency, and reduce dependence on manual processes. This functional versatility and scalability make software platforms the most widely adopted segment in neurodiversity assessment and screening solutions.

The adults (18+ years) segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the adults (18+ years) segment is predicted to witness the highest growth rate. Growing awareness that conditions such as ADHD, autism, and dyslexia persist into adulthood has encouraged more individuals to pursue evaluations. Organizations and universities increasingly use digital platforms to identify support needs and improve inclusion strategies. Adults prefer flexible, private, and online screening options that fit busy lifestyles. This shift toward adult-focused assessments, combined with workplace inclusion initiatives and rising self-advocacy, is accelerating adoption and positioning the adult segment as the highest-growth category in the market.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, supported by well-developed technology ecosystems and strong recognition of neurodiverse needs. The region benefits from early integration of digital solutions across healthcare, education, and employment sectors. Organizations actively use screening platforms to support inclusion, compliance, and early intervention initiatives. Availability of skilled professionals, favorable regulatory environments, and high adoption of remote assessment tools enhance market penetration. These combined factors position North America as the leading region in terms of overall market share.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by improving awareness and expanding digital infrastructure. Educational institutions and healthcare organizations are turning to online screening solutions to meet growing demand efficiently. Supportive government programs, increased access to mobile technologies, and a rising emphasis on inclusive learning contribute to adoption. With a large and diverse population seeking accessible assessment options, the region is experiencing rapid uptake of digital neurodiversity platforms, making Asia Pacific the highest-growth market segment globally.

Key players in the market

Some of the key players in Neurodiversity Assessment & Screening Platforms Market include Lumosity, MoCA Cognition, HappyNeuron, Cognistat, BrainFx, Dystech, CogniFit, Cambridge Cognition, Creyos Health, CNS Vital Signs, Do-IT Profiler, GL Assessment, Qbtech, Gabify and Aignosis.

Key Developments:

In June 2025, Qbtech announces the formation of its Houston-based clinical research and strategic partnership teams, along with new staff appointments and promotions at the company's US headquarters. The employee expansions bolster the company's continued growth in the region, enhancing its capabilities and market presence as it continues to develop and enhance its software solutions.

In October 2016, CogniFit introduces CogniFit for Education, a new web-portal for teachers to assess, train, and monitor cognitive skills involved in the learning processes. The CogniFit for Education platform starts with students completing a scientifically validated and gamified cognitive assessment.

Components Covered:

  • Software Platforms
  • Services

Age Groups Covered:

  • Children (0-12 years)
  • Adolescents (13-17 years)
  • Adults (18+ years)

Deployment Modes Covered:

  • Cloud-Based
  • On-Premise

Applications Covered:

  • Dyslexia Screening
  • ADHD Screening
  • Autism Spectrum Disorder (ASD) Screening
  • Dyspraxia Screening

End Users Covered:

  • Educational Institutions
  • Healthcare Providers
  • Corporate Organizations
  • Research Institutes
  • Government Agencies

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Neurodiversity Assessment & Screening Platforms Market, By Component

  • 5.1 Introduction
  • 5.2 Software Platforms
  • 5.3 Services

6 Global Neurodiversity Assessment & Screening Platforms Market, By Age Group

  • 6.1 Introduction
  • 6.2 Children (0-12 years)
  • 6.3 Adolescents (13-17 years)
  • 6.4 Adults (18+ years)

7 Global Neurodiversity Assessment & Screening Platforms Market, By Deployment Mode

  • 7.1 Introduction
  • 7.2 Cloud-Based
  • 7.3 On-Premise

8 Global Neurodiversity Assessment & Screening Platforms Market, By Application

  • 8.1 Introduction
  • 8.2 Dyslexia Screening
  • 8.3 ADHD Screening
  • 8.4 Autism Spectrum Disorder (ASD) Screening
  • 8.5 Dyspraxia Screening

9 Global Neurodiversity Assessment & Screening Platforms Market, By End User

  • 9.1 Introduction
  • 9.2 Educational Institutions
  • 9.3 Healthcare Providers
  • 9.4 Corporate Organizations
  • 9.5 Research Institutes
  • 9.6 Government Agencies

10 Global Neurodiversity Assessment & Screening Platforms Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Lumosity
  • 12.2 MoCA Cognition
  • 12.3 HappyNeuron
  • 12.4 Cognistat
  • 12.5 BrainFx
  • 12.6 Dystech
  • 12.7 CogniFit
  • 12.8 Cambridge Cognition
  • 12.9 Creyos Health
  • 12.10 CNS Vital Signs
  • 12.11 Do-IT Profiler
  • 12.12 GL Assessment
  • 12.13 Qbtech
  • 12.14 Gabify
  • 12.15 Aignosis

List of Tables

  • Table 1 Global Neurodiversity Assessment & Screening Platforms Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Neurodiversity Assessment & Screening Platforms Market Outlook, By Component (2024-2032) ($MN)
  • Table 3 Global Neurodiversity Assessment & Screening Platforms Market Outlook, By Software Platforms (2024-2032) ($MN)
  • Table 4 Global Neurodiversity Assessment & Screening Platforms Market Outlook, By Services (2024-2032) ($MN)
  • Table 5 Global Neurodiversity Assessment & Screening Platforms Market Outlook, By Age Group (2024-2032) ($MN)
  • Table 6 Global Neurodiversity Assessment & Screening Platforms Market Outlook, By Children (0-12 years) (2024-2032) ($MN)
  • Table 7 Global Neurodiversity Assessment & Screening Platforms Market Outlook, By Adolescents (13-17 years) (2024-2032) ($MN)
  • Table 8 Global Neurodiversity Assessment & Screening Platforms Market Outlook, By Adults (18+ years) (2024-2032) ($MN)
  • Table 9 Global Neurodiversity Assessment & Screening Platforms Market Outlook, By Deployment Mode (2024-2032) ($MN)
  • Table 10 Global Neurodiversity Assessment & Screening Platforms Market Outlook, By Cloud-Based (2024-2032) ($MN)
  • Table 11 Global Neurodiversity Assessment & Screening Platforms Market Outlook, By On-Premise (2024-2032) ($MN)
  • Table 12 Global Neurodiversity Assessment & Screening Platforms Market Outlook, By Application (2024-2032) ($MN)
  • Table 13 Global Neurodiversity Assessment & Screening Platforms Market Outlook, By Dyslexia Screening (2024-2032) ($MN)
  • Table 14 Global Neurodiversity Assessment & Screening Platforms Market Outlook, By ADHD Screening (2024-2032) ($MN)
  • Table 15 Global Neurodiversity Assessment & Screening Platforms Market Outlook, By Autism Spectrum Disorder (ASD) Screening (2024-2032) ($MN)
  • Table 16 Global Neurodiversity Assessment & Screening Platforms Market Outlook, By Dyspraxia Screening (2024-2032) ($MN)
  • Table 17 Global Neurodiversity Assessment & Screening Platforms Market Outlook, By End User (2024-2032) ($MN)
  • Table 18 Global Neurodiversity Assessment & Screening Platforms Market Outlook, By Educational Institutions (2024-2032) ($MN)
  • Table 19 Global Neurodiversity Assessment & Screening Platforms Market Outlook, By Healthcare Providers (2024-2032) ($MN)
  • Table 20 Global Neurodiversity Assessment & Screening Platforms Market Outlook, By Corporate Organizations (2024-2032) ($MN)
  • Table 21 Global Neurodiversity Assessment & Screening Platforms Market Outlook, By Research Institutes (2024-2032) ($MN)
  • Table 22 Global Neurodiversity Assessment & Screening Platforms Market Outlook, By Government Agencies (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.